# Cardiovascular System & Cardiology

## Fetal Circulation

![](../Figures/Fetal%20Circulation.png)

## Heart Development

|Mnemonic|Embryonic structure|Derivatives|
|-|-|-|
|Small|Sinus venosus|Smooth part of RA & Coronary sinus|
|Pump|Primitive atrium|Trabeculated part of RA & LA|
|Produces|Primitive ventricle|Trabeculated part of RV & LV|
|Big|Bulbus cordis|Smooth part of RV & LV|
|Turbulence|Truncus arteriosus|Aortic & Pulmonary trunk|

## Layers of Arteries

|Layer|Elastic Artery|Muscular Artery|Arteriole|
|-|-|-|-|
|Tunica adventitia|+|+|+|
|External elastic layer|-|Elastin|-|
|Tunica media|Elastin|Smooth muscle|Smooth muscle|
|Internal elastic layer|-|Elastin|-|
|Tunica intima|+|+|+|

## Action Potential of Cardiac Muscle Cells

|Phase|SA & AV Nodes|Atria & Ventricles|
|-|-|-|
|0|Ca current|Na current|
|1|-|K current|
|2|-|Ca & K current|
|3|K current|K current|
|4|Funny current: Na & K current|Leak current: K current|

## Factors Affecting Stroke Volume {CAP}

- Contractility
- Afterload
- Preload

## Cardiac & Vascular Function Curves

|Label|Examples|
|-|-|
|1|Catecholamines & Digoxin|
|2|Heart failure & Narcotics|
|3|Venopressors & Infusion|
|4|Venodilators & Hemorrhage & Spinal anesthesia|
|5|Vasopressors|
|6|Vasodilators & AV shunt|

![](../Figures/Cardiac%20and%20Vascular%20Function%20Curves.png)

## Heart Sounds

|Heart Sound|Synonym|Etiology|Pathology|Examples|
|-|-|-|-|-|
|S<sub>1</sub>|-|MV & TV closure|-|-|
|S<sub>2</sub>|-|AV & PV closure|-|-|
|S<sub>3</sub>|Ventricular gallop & Opening snap|MV & TV opening|Volume overload|HF & DCMP & MR & TR|
|S<sub>4</sub>|Atrial gallop & Atrial kick|Atrial contraction|Diastolic dysfunction|HF & HCMP|

## Splitting

|Type|Etiology|
|-|-|
|Normal|-|
|Wide|Pulmonary stenosis & RBBB|
|Fixed|ASD|
|Paradoxical|Aortic stenosis & LBBB|

## Virchow Triad for Thrombosis {SHE}

- Stasis of blood flow
- Hypercoagulability
- Endothelial injury

## Effects of Adrenergic Agents

|Agent|CO|SVR|MAP|
|-|-|-|-|
|α<sub>1</sub>|↓|↑ (1°)|↑|
|α<sub>2</sub>|↓|↓|↓|
|β<sub>1</sub>|↑ (1°)|-|↑|
|β<sub>2</sub>|↑|↓ (1°)|↓|
|Dopamine: D > β<sub>1</sub> > α<sub>1</sub>|↑ (1°)|-|↑|
|Dobutamine: β<sub>1</sub> > β<sub>2</sub>|↑ (1°)|↓|↑|
|Norepinephrine: α<sub>1</sub> > β<sub>1</sub>|-|↑ (1°)|↑|
|Epinephrine: β > α<sub>1</sub>|↑ (1°)|-|↑|
|Isoproterenol: β<sub>1</sub> = β<sub>2</sub>|↑ (1°)|↓ (1°)|-|

## Mechanisms of Action of Venodilators

|Mechanism|Medication|Indications|
|-|-|-|
|μ-opioid agonists|Morphine|Venodilation|
|NO donors|Nitroglycerin & Isosorbide|Venodilation|

## Mechanisms of Action of Vasodilators

|Mechanism|Medication|Indications|
|-|-|-|
|α<sub>1</sub> antagonists|Terazosin<br>Doxazosin<br>Prazosin|Vasodilation|
|α<sub>2</sub> agonists|Clonidine<br>Methyldopa|Vasodilation|
|Ca channel blockers|-Dipines|Vasodilation|
|K channel activators|Minoxidil<br>Diazoxide|Vasodilation|
|NO donors|Nitroprusside<br>Hydralazine|Vasodilation|
|PDE inhibitors|Dipyridamole<br>Cilostazol|Vasodilation|
|A<sub>1</sub> agonists|Adenosine|Vasodilation|

## Mechanisms of Action of Inotropes

|Mechanism|Medication|Indications|
|-|-|-|
|β<sub>1</sub> agonists|Dopamine: D > β<sub>1</sub> > α<sub>1</sub>|Inotrope|
||Dobutamine: β<sub>1</sub> > β<sub>2</sub>|Inotrope|
||Norepinephrine: α<sub>1</sub> > β<sub>1</sub>|Inotrope|
||Epinephrine: β > α<sub>1</sub>|Inotrope|
||Isoproterenol: β|Inotrope|
|PDE inhibitors|Inamrinone & Milrinone|Inotrope|
|Na-K pump blockers|Digoxin & Digitalis|Inotrope|

## Inotropic Equivalent (IE)

|Inotrope|Equivalent|
|-|-|
|Dopamine|1|
|Dobutamine|1|
|Milrinone|15|
|Norepinephrine|100|
|Epinephrine|100|
|Isoproterenol|100|

## Medications Slowing Conduction {ABCD}

- Adenosine
- β antagonists
- Ca channel blockers
- Digoxin & Digitalis

## Physical Examination for Cardiovascular System

|Finding|Indications|
|-|-|
|Pulsus paradoxus|Cardiac tamponade & Obstructive lung diseases|
|Pulsus parvus et tardus|Aortic stenosis|
|Pulsus alternans|LV systolic dysfunction|
|Differential cyanosis :: lower limbs|Eisenmenger syndrome of PDA|
|Reverse differential cyanosis :: upper limbs|Transposition of great artery (TGA)|
|Kussmaul sign|Cardiac tamponade & Right heart failure & Restrictive cardiomyopathy|

## Grading of Murmurs

|Grade|Thrill|Stethoscope|
|-|-|-|
|1|-|Against|
|2|-|Against|
|3|-|Against|
|4|+|Against|
|5|+|Partially off|
|6|+|Completely off|

## Approach to ECG

- Rate
- Rhythm
- Axis
- Interval
- Morphology

## Localization on ECG

|Location|Artery|Leads|
|-|-|-|
|Septal|LAD|V1 & V2|
|Anterior|LAD|V3 & V4|
|Apical|LAD / LCX / RCA|V5 & V6|
|Lateral|LCX|I & aVL|
|Inferior|RCA & LCX|II & III & aVF|
|Posterior|RCA / LCX|V1 & V2 & V3|

![](../Figures/Localization%20on%20ECG.png)

## Views of Echocardiography

![](../Figures/Views%20of%20Echocardiography.png)

## Cardiac Stress Test

- Exercise :: treadmill & bicycle
- Dobutamine
- Vasodilators :: Dipyridamole & Adenosine

## Atrial Septal Defects (ASD)

|Type|Prevalence|
|-|-|
|Secundum|70%|
|Primum|20%|
|Sinus venosus|10%|
|Coronary sinus|< 1%|

![](../Figures/Atrial%20Septal%20Defects%20(ASD).jpg)

## Ventricular Septal Defects (VSD)

![](../Figures/Ventricular%20Septal%20Defects%20(VSD).png)

## Cyanotic Congenital Heart Defects (CHD) {5T-HE}

|Defect|Obligatory Shunt|Cyanosis|
|-|-|-|
|Truncus arteriosus|-|Non-differential|
|Transposition of great artery (TGA)|(ASD / VSD) & PDA|Reverse differential|
|Tricuspid atresia|ASD & (VSD / PDA)|Non-differential|
|Tetralogy of Fallot (TOF)|VSD & PDA|Non-differential|
|Total anomalous pulmonary venous return (TAPVR)|ASD / VSD / PDA|Non-differential|
|Hypoplastic left heart syndrome (HLHS)|ASD & PDA|Non-differential|
|Eisenmenger syndrome of ASD|-|Non-differential|
|Eisenmenger syndrome of VSD|-|Non-differential|
|Eisenmenger syndrome of PDA|-|Differential|

## PDA-dependent Cyanotic Congenital Heart Defects (CHD)

- Transposition of great artery (TGA)
- Tetralogy of Fallot (TOF)
- Hypoplastic left heart syndrome (HLHS)
- Critical pulmonary stenosis
- Critical aortic stenosis
- Critical coarctation of aorta (CoA)

## Presentation of Tetralogy of Fallot (TOF) {PROV}

- Pulmonary stenosis
- RV hypertrophy
- Overriding aorta
- Ventricular septal defect

## Classification of Shocks

|Shock|PCWP|CO|SVR|MAP|Treatment|
|-|-|-|-|-|-|
|Hypovolemic|↓ (1°)|↓|↑|↓|Fluids|
|Cardiogenic|↑|↓ (1°)|↑|↓|Inotropes & Diuretics & Venodilators|
|Distributive|-|↑|↓ (1°)|↓|Vasopressors|
|Neurogenic|↓|↓ (1°)|↓ (1°)|↓|Vasopressors|

## Classification of Hypovolemic Shock

|Class|Loss|HR|BP|RR|Urine|
|-|-|-|-|-|-|
|I|< 15%|< 100|-|12 ~ 20|> 30 mL/h|
|II|15 ~ 30%|100 ~ 120|-|20 ~ 30|20 ~ 30 mL/h|
|III|30 ~ 40%|120 ~ 140|↓|30 ~ 40|5 ~ 15 mL/h|
|IV|> 40%|> 140|↓|> 35|< 5 mL/h|

## Classification of Heart Failure (HF)

||HFrEF|HFpEF|
|-|-|-|
|LVEDV|↑|↓|
|LVESV|↑|↓|
|SV|↓|↓|
|LVEF|↓|-|
|Dysfunction|Systolic|Diastolic|
|Etiology|ACS & DCMP|HCMP & RCMP|

## Staging of Heart Failure (HF)

### NYHA

![](../Figures/NYHA%20Functional%20Classes.png)

### ACC/AHA

![](../Figures/ACC-AHA%20Stages%20of%20Heart%20Failure.png)

## Treatment of Heart failure (HF)

### Decompensated {LMNOP}

- Diuretics :: Lasix
- Venodilators :: Morphine & NO donors
- Oxygen
- Position

### Compensated {ABDV}

- ACEI & ARB
- β<sub>1</sub> antagonists :: Carvedilol & Bisoprolol & Metoprolol
- Digoxin & Diuretics :: Spironolactone
- Vasodilators :: NO donors

## Etiology of Dilated Cardiomyopathy (DCMP) {ABCD}

- Alcohol
- Beriberi & Vitamin B1 deficiency
- Coxsackie B virus myocarditis
- Cocaine
- Chagas disease
- Doxorubicin
- Duchenne muscular dystrophy

## Etiology of Arrhythmia {HIS-BEDS}

- Hypoxia
- Ischemia & Irritability
- Sympathetic tone
- Bradycardia
- Electrolyte disturbances
- Drugs
- Stretch

## Pathogenesis of Arrhythmias

- Automaticity
- Triggered activity
	- Early after-depolarization (EAD)
	- Delayed after-depolarization (DAD)
- Reentry
- Conduction delay

## Classification of Arrhythmias

### Sinus Arrhythmias

- Sinus bradycardia
- Sinus tachycardia

### Supraventricular Arrhythmias :: Atrial

- Atrial tachycardia (AT)
	- Focal atrial tachycardia (FAT)
	- Multifocal atrial tachycardia (MAT)
- Atrial flutter
- Atrial fibrillation (AF)

### Supraventricular Arrhythmias :: Junctional

- Junctional escape [Idiojunctional] rhythm
- Junctional tachycardia (JT)
- AV nodal reentrant tachycardia (AVNRT)
- AV reentrant/reciprocating tachycardia (AVRT)

### Ventricular Arrhythmias

- Ventricular escape [Idioventricular] rhythm
- Ventricular tachycardia (VT)
- Ventricular fibrillation (VF)

## Types of Pre-excitation

![](../Figures/Types%20of%20Pre-excitation.png)

## Rules of Malignancy for PVC

- Frequent PVC
- Consecutive PVC
- R-on-T phenomenon
- Acute myocardial infraction
- Multiform PVC

## Correlation of ECG with Antiarrhythmics

|ECG|Heart|Phase|Ion Channel|Antiarrhythmics|
|-|-|-|-|-|
|Heart rate|SA node|4|Na & K|Class 2|
|PR interval|AV node|0|Ca|Class 2 & 4|
|QRS complex|Ventricle|0|Na|Class 1|
|QT interval|Ventricle|2 & 3|K|Class 1 & 3|

## Mechanisms of Action of Antiarrhythmics

|Mechanism|Medication|Indications|
|-|-|-|
|Class 1A: Na channel blockers|Quinidine|Arrhythmia|
||Procainamide|Arrhythmia|
||Disopyramide|Arrhythmia|
|Class 1B: Na channel blockers|Lidocaine|Arrhythmia|
||Mexiletine|Arrhythmia|
|Class 1C: Na channel blockers|Flecainide|Arrhythmia|
||Propafenone|Arrhythmia|
|Class 2: β antagonists|-|Arrhythmia|
|Class 3: K channel blockers|Amiodarone|Arrhythmia|
||Ibutilide|Arrhythmia|
||Dofetilide|Arrhythmia|
||Sotalol|Arrhythmia|
|Class 4: Ca channel blockers|Verapamil|Arrhythmia|
||Diltiazem|Arrhythmia|
|Miscellaneous|Digoxin & Digitalis|Arrhythmia|
||Adenosine|Arrhythmia|
||Magnesium|Arrhythmia|

## Contraindications for Amiodarone

- Sinus bradycardia :: < 40 & symptomatic
- Sick sinus syndrome
- AV blocks :: 2nd & 3rd degree
- QT prolongation
- Wolff-Parkinson-White (WPW) syndrome
- Cardiogenic shock

## Risk of Stroke from Atrial Fibrillation

### CHADS<sub>2</sub> Score

- Congestive heart failure (CHF)
- Hypertension
- Age ≥ 75
- Diabetes mellitus
- Stroke / CVA history

### CHA<sub>2</sub>DS<sub>2</sub>-VASc Score

- Congestive heart failure (CHF)
- Hypertension
- Age ≥ 75
- Diabetes mellitus
- Stroke / CVA history
- Vascular diseases
- Age 65 ~ 75
- Sex :: female

## Treatment of Atrial Fibrillation

- Cardioversion
	- Duration < 48 hours<br>Hemodynamically unstable
	- Anticoagulated<br>No atrial thrombus on TEE
- Anticoagulants
	- Duration > 48 hours
	- CHA<sub>2</sub>DS<sub>2</sub>-VASc ≥ 2
- Antiarrhythmics
	- Rate control :: Class 2 & 4 & Digoxin
	- Rhythm control :: Class 1 & 3

## Etiology of Torsades de Pointes

- QT prolongation
- Hypokalemia
- Hypomagnesemia

## Etiology of ST Segment Elevation

- Acute myocardial infarction
- Acute myocarditis
- Acute pericarditis
- Apical ballooning syndrome
- Brugada syndrome
- Hyperkalemia
- Hypothermia
- J point elevation
- Pulmonary embolism
- Variant angina

## Risk Factors for Coronay Artery Disease (CAD)

- Age ≥ 45 in males / ≥ 55 in females
- Cigarette smoking
- Family history of premature CAD
- Hypertension
- HDL < 40 mg/dL

## Pathogenesis & Presentation of Acute Coronary Syndrome (ACS)

|Types|Pathogenesis|T Wave|ST Segment|Q Wave|Triggers|Cardiac Enzymes|
|-|-|-|-|-|-|-|
|Stable angina|Coronary artery thrombosis|-|STD|-|Exertion|-|
|Unstable angina|Coronary artery thrombosis|TWI|STD|-|Anytime|-|
|Variant [Prinzmetal] angina|Coronary artery spasm|HTW|STE|-|Drugs|-|
|NSTEMI [NQMI]|Subendocardial infarction|TWI|STD|-|Anytime|↑|
|STEMI [QWMI]|Transmural infarction|HTW|STE|PQW|Anytime|↑|

## Complications of Myocardial Infarction

|Time|Histology|Presentation|
|-|-|-|
|< 1 day|Coagulative necrosis|Cardiogenic shock|
||Contraction bank|Arrhythmia|
||Wavy fiber|-|
|1 ~ 3 days|-|Post-infarction fibrinous pericarditis|
|3 ~ 14 days|Granulation tissue|Pseudo-aneurysm|
||-|Cardiac tamponade|
|> 14 days|Contracted scar|Aneurysm|
||-|Dressler syndrome|

## Thrombolysis in Myocardial Infarction (TIMI) Score for NSTEMI {ACS}

- Age ≥ 75
- Aspirin use
- Angina ≥ 2 in 24 hours
- CAD risk factors ≥ 3
- Cardiac enzymes
- ST changes ≥ 0.5 mm

## Treatment of Acute Coronary Syndrome (ACS) {MONAB}

- Venodilators :: Morphine & NO donors
- Oxygen
- Antiplatelets :: Aspirin & ADP antagonists
- Anticoagulants :: Heparin
- β<sub>1</sub> antagonists

## Ideal Length of Time Between Presentation and Therapy for ACS

- Door-to-needle < 30 minutes
- Door-to-bolloon < 90 minutes

## Indications for Coronary Artery Bypass Grafting (CABG)

- LCA > 50% stenosis
- Proximal LAD > 50% stenosis
- 2-vessel disease: 2 vessels > 50% stenosis & EF < 50%
- 3-vessel disease: 3 vessels > 50% stenosis

## Types of Grafts for Coronary Artery Bypass Grafting (CABG)

- Saphenous vein graft
- Internal mammary artery (IMA) graft
	- Left internal mammary artery (LIMA) graft
	- Right internal mammary artery (RIMA) graft
- Radial artery graft

## Comparison Between Biosprosthetic and Mechanical Heart Valves

- Mortality: biosprosthetic > mechanical
- Durability: biosprosthetic < mechanical
- Bleeding: biosprosthetic < mechanical
- Thromboembolism: biosprosthetic < mechanical

## Beck Triad of Cardiac Tamponade

- Hypotension & Pulsus paradoxus
- Jugular vein distension (JVD) & Kussmaul sign
- Distant heart sound

## Treatment of Hypertension {ABDV}

- ACEI & ARB
- β<sub>1</sub> antagonists
- Diuretics
- Vasodilators

## Treatment of Hypertensive Emergency

- β<sub>1</sub> antagonists :: Labetalol
- Venodilators & Vasodilators :: NO donors & Ca channel blockers

## Fontaine Staging of Peripheral Artery Disease (PAD)

|Stage|Symptoms|
|-|-|
|1|Asymptomatic|
|2|Intermittent claudication|
|3|Ischemic rest pain|
|4|Ulceration & Gangrene|

![](../Figures/Fontaine%20Staging%20of%20Peripheral%20Artery%20Disease%20(PAD).png)

## Treatment of Peripheral Artery Disease (PAD)

- PDE inhibitors :: Cilostazol
- PGE1 agonists :: Alprostadil
- Antiplatelets :: Aspirin & ADP antagonists
- Revascularization :: percutaneous intervention & bypass grafting

## Vasculitis

- Large-vessel
	- Takayasu arteritis
	- Giant cell arteritis [Temporal arteritis]
- Medium-vessel
	- Kawasaki disease
	- Polyarteritis nodosa
	- Thromboangiitis obliterans [Buerger disease]
- Small-vessel
	- ANCA-associated vasculitis (AAV)
		- Granulomatosis with polyangiitis (GPA) [Wegener's granulomatosis]
		- Eosinophilic granulomatosis with polyangiitis (EGPA) [Churg-Strauss syndrome]
		- Microscopic polyangiitis
	- IgA vasculitis [Henoch-Schonlein purpura (HSP)]
	- Cryoglobulinemic vasculitis

![](../Figures/Vasculitis.png)

## Indications for Defibrillation

- Pulseless monomorphic VT: 120 ~ 200 J
- Polymorphic VT: 120 ~ 200 J
- VF: 120 ~ 200 J

## Indications for Synchronized Cardioversion

- Unstable narrow-QRS tachycardia: 50 ~ 100 J
- Unstable atrial flutter: 50 ~ 100 J
- Unstable atrial fibrillation: 120 ~ 200 J
- Unstable monomorphic VT: > 100 J

## Indications for Permanent Pacemaker

- Sinus bradycardia :: < 40 & symptomatic
- Sick sinus syndrome
- AV blocks :: 2nd degree Mobitz II & 3rd degree

## Pathogens of Infective Endocarditis

- Staphylococcus aureus
- Staphylococcus epidermidis
- Streptococcus viridans
- Enterococcus
- Pseudomonas aeruginosa
- Candida

## Pathogens of Culture-Negative Infective Endocarditis {HACEK}

- Haemophilus parainfluenzae
- Actinobacillus
- Cardiobacterium
- Eikenella
- Kingella

## Presentation of Infective Endocarditis {FROM-JANE}

- Fever
- Roth spots
- Osler nodes
- Murmur
- Janeway lesions
- Anemia
- Nail-bed hemorrhage
- Emboli

## Duke Criteria for Infective Endocarditis

- Major
	- Microbiological evidence
	- Endocardial involvement
- Minor
	- Fever
	- Vascular phenomena
	- Immunologic phenomena
	- Microbiological evidence
	- Risk factors
